As of 2025-09-18, the Relative Valuation of Gemina Laboratories Ltd (GLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 CAD, the upside of Gemina Laboratories Ltd based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-09-12 | -8.71 |
| 2025-09-11 | -8.71 |
| 2025-09-09 | -5.07 |
| 2025-09-05 | -6.81 |
| 2025-09-03 | -7.13 |
| 2025-09-02 | -6.34 |
| 2025-08-27 | -7.76 |
| 2025-08-26 | -7.92 |
| 2025-08-25 | -7.92 |
| 2025-08-21 | -9.50 |
| 2025-08-15 | -7.92 |
| 2025-08-14 | -7.92 |
| 2025-08-13 | -7.92 |
| 2025-08-12 | -9.19 |
| 2025-08-07 | -9.50 |
| 2025-08-06 | -10.61 |
| 2025-08-05 | -11.72 |
| 2025-07-30 | -11.88 |
| 2025-07-29 | -10.77 |
| 2025-07-28 | -8.39 |
| 2025-07-23 | -10.29 |
| 2025-07-16 | -10.29 |
| 2025-07-11 | -11.09 |
| 2025-07-09 | -11.72 |
| 2025-07-04 | -12.20 |
| 2025-07-03 | -10.61 |
| 2025-07-02 | -11.09 |
| 2025-06-27 | -12.35 |
| 2025-06-26 | -12.35 |